SCHEMBL9078409

SCHEMBL9078409

Oc1nc2cccc(Cl)c2nc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.46
ACHE P22303 1/20 0.43
ALDH1A1 P00352 5/20 0.39
RAB9A P51151 2/20 0.39
GAA P10253 2/20 0.39
MAPT P10636 2/20 0.39
KMT2A Q03164 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
ADORA3 P0DMS8 1/20 0.36
ADORA1 P30542 1/20 0.36
PSMB8 P28062 3/20 0.36
TSHR P16473 1/20 0.35
LMNA P02545 2/20 0.35
PDE10A Q9Y233 1/20 0.35
KDM4E B2RXH2 2/20 0.35
GLA P06280 1/20 0.35
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
PRMT5 O14744 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27761307 0.88 NQO2 (0.48) NQO2ACHEALDH1A1RAB9AGAA
SCHEMBL7527351 0.83 TDP1 (0.56) NQO2ACHEALDH1A1RAB9AGAA
SCHEMBL4566447 0.81 NR1H2 (0.44) NQO2ACHEALDH1A1RAB9AGAA
SCHEMBL23589560 0.80 NQO2 (0.52) NQO2ACHEALDH1A1RAB9AGAA
SCHEMBL31558290 0.80 NQO2 (0.52) NQO2ACHEALDH1A1RAB9AGAA
SCHEMBL23612586 0.78 ACHE (0.75) NQO2ACHEALDH1A1RAB9AGAA
SCHEMBL4180819 0.77 NQO2 (0.43) NQO2ACHEALDH1A1RAB9AGAA
SCHEMBL874110 0.76 TDP1 (0.67) NQO2ALDH1A1RAB9AGAAMAPT
SCHEMBL4181275 0.76 NR1H2 (0.43) NQO2MAPTTDP1ADORA3ADORA1
SCHEMBL11808972 0.75 ADORA3 (0.41) NQO2ACHEALDH1A1RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5529999-A SULFONAMIDOQUINOXALINE DERIVATIVE ELI LILLY AND COMPANY (US) 1996-06-25 US disclosed
EP-0672662-A1 Quinoxaline derivative used in the treatment of tumours ELI LILLY AND COMPANY (US) 1995-09-20 EP disclosed